278 related articles for article (PubMed ID: 31715603)
1. Silencing of Proteasome 26S Subunit ATPase 2 Regulates Colorectal Cancer Cell Proliferation, Apoptosis, and Migration.
He J; Xing J; Yang X; Zhang C; Zhang Y; Wang H; Xu X; Wang H; Cao Y; Xu H; Zhang C; Wang C; Yu E
Chemotherapy; 2019; 64(3):146-154. PubMed ID: 31715603
[TBL] [Abstract][Full Text] [Related]
2. PSMC2 is up-regulated in osteosarcoma and regulates osteosarcoma cell proliferation, apoptosis and migration.
Song M; Wang Y; Zhang Z; Wang S
Oncotarget; 2017 Jan; 8(1):933-953. PubMed ID: 27888613
[TBL] [Abstract][Full Text] [Related]
3. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of PSMC2 contributes to suppression of cholangiocarcinoma development by regulating CDK1.
Duan X; Yang J; Jiang B; Duan W; Wei R; Zhang H; Mao X
Aging (Albany NY); 2021 Sep; 13(17):21325-21344. PubMed ID: 34499615
[TBL] [Abstract][Full Text] [Related]
5. Lower miR-630 expression predicts poor prognosis of osteosarcoma and promotes cell proliferation, migration and invasion by targeting PSMC2.
Li GW; Yan X
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1915-1925. PubMed ID: 30915734
[TBL] [Abstract][Full Text] [Related]
6. PSMC2/CCND1 axis promotes development of ovarian cancer through regulating cell growth, apoptosis and migration.
Zhu D; Huang J; Liu N; Li W; Yan L
Cell Death Dis; 2021 Jul; 12(8):730. PubMed ID: 34294689
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of PSMC2 promotes the tumorigenesis and development of human breast cancer via regulating plasminogen activator urokinase (PLAU).
Wang Y; Zhu M; Li J; Xiong Y; Wang J; Jing H; Gu Y
Cell Death Dis; 2021 Jul; 12(7):690. PubMed ID: 34244472
[TBL] [Abstract][Full Text] [Related]
8. PSMC2 is overexpressed in glioma and promotes proliferation and anti-apoptosis of glioma cells.
Zheng X; Wang Y; Wang D; Wan J; Qin X; Mu Z; Hu N
World J Surg Oncol; 2022 Mar; 20(1):84. PubMed ID: 35287689
[TBL] [Abstract][Full Text] [Related]
9. Silencing of PSMC2 inhibits development and metastasis of prostate cancer through regulating proliferation, apoptosis and migration.
Chen Q; Fu L; Hu J; Guo G; Xie A
Cancer Cell Int; 2021 Apr; 21(1):235. PubMed ID: 33902600
[TBL] [Abstract][Full Text] [Related]
10. PSMC2 knockdown exerts an anti-tumor role in nasopharyngeal carcinoma through regulating AKT signaling pathway.
Su J; Hu S; Ding S; Feng K
Cell Cycle; 2023 Nov; 22(21-22):2381-2391. PubMed ID: 38123344
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of UQCRC2 is correlated with tumor progression and poor prognosis in colorectal cancer.
Shang Y; Zhang F; Li D; Li C; Li H; Jiang Y; Zhang D
Pathol Res Pract; 2018 Oct; 214(10):1613-1620. PubMed ID: 30115536
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of thyroid hormone receptor interactor 13 is associated with human hepatocellular carcinoma.
Ju L; Li X; Shao J; Lu R; Wang Y; Bian Z
Oncol Rep; 2018 Dec; 40(6):3794-3802. PubMed ID: 30542731
[TBL] [Abstract][Full Text] [Related]
13. High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer.
Yi W; Xiao E; Ding R; Luo P; Yang Y
Oncol Rep; 2016 Dec; 36(6):3145-3153. PubMed ID: 27748871
[TBL] [Abstract][Full Text] [Related]
14. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
[TBL] [Abstract][Full Text] [Related]
15. The Silence of PSMC6 Inhibits Cell Growth and Metastasis in Lung Adenocarcinoma.
Zhang JY; Shi KZ; Liao XY; Li SJ; Bao D; Qian Y; Li DJ
Biomed Res Int; 2021; 2021():9922185. PubMed ID: 34239933
[TBL] [Abstract][Full Text] [Related]
16. PSMC2 promotes glioma progression by regulating immune microenvironment and PI3K/AKT/mTOR pathway.
Wang Y; Zhang S; Zhao Z; Jin Q; Wang Z; Song Z; Liu L; Zhao Z
Immunobiology; 2024 May; 229(3):152802. PubMed ID: 38569452
[TBL] [Abstract][Full Text] [Related]
17. Silencing Proteasome 26S Subunit ATPase 2 (PSMC2) Protects the Osteogenic Differentiation In Vitro and Osteogenesis In Vivo.
Zhou B; Peng K; Wang G; Chen W; Kang Y
Calcif Tissue Int; 2021 Jul; 109(1):44-54. PubMed ID: 33625534
[TBL] [Abstract][Full Text] [Related]
18. The Novel Long Noncoding RNA TUSC7 Inhibits Proliferation by Sponging MiR-211 in Colorectal Cancer.
Xu J; Zhang R; Zhao J
Cell Physiol Biochem; 2017; 41(2):635-644. PubMed ID: 28214867
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer.
Wu Y; Song Y; Xiong Y; Wang X; Xu K; Han B; Bai Y; Li L; Zhang Y; Zhou L
Cell Physiol Biochem; 2017; 43(3):945-958. PubMed ID: 28957811
[TBL] [Abstract][Full Text] [Related]
20. Immature Colon Carcinoma Transcript-1 (ICT1) Expression Correlates with Unfavorable Prognosis and Survival in Patients with Colorectal Cancer.
Lao X; Feng Q; He G; Ji M; Zhu D; Xu P; Tang W; Xu J; Qin X
Ann Surg Oncol; 2016 Nov; 23(12):3924-3933. PubMed ID: 27411551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]